Assetmark, Inc Bausch Health Companies Inc. Transaction History

Assetmark, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$7.06 - $23.63 $60,299 - $201,823	8,541 Added 454.31%	10,421 $87,000
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $40,608 - $52,245	1,880 New	1,880 $43,000
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1,752 - $2,104	-70 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $71,929 - $97,308	-4,834 Reduced 98.57%	70 $1,000
Q2 2020 Aug 11, 2020	SELL	$13.31 - $20.51 $39,703 - $61,181	-2,983 Reduced 37.82%	4,904 $90,000
Q1 2020 May 12, 2020	SELL	$12.98 - $30.25 $1,570 - $3,660	-121 Reduced 1.51%	7,887 $122,000
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $1,586 - $2,678	84 Added 1.06%	8,008 $240,000
Q3 2019 Nov 13, 2019	SELL	$20.88 - $25.66 $2,108 - $2,591	-101 Reduced 1.26%	7,924 $173,000
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $6,217 - $8,014	303 Added 3.92%	8,025 $202,000
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $24,255 - $31,521	-1,199 Reduced 13.44%	7,722 $191,000
Q4 2018 Feb 13, 2019	SELL	$17.64 - $28.32 $32,581 - $52,307	-1,847 Reduced 17.15%	8,921 $165,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $222,251 - $276,414	10,768 New	10,768 $276,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.